Jason Brown - Sep 29, 2023 Form 3 Insider Report for Karuna Therapeutics, Inc. (KRTX)

Role: Chief Financial Officer
Signature: /s/ Mia Kelley, Attorney-in-Fact
Stock symbol: KRTX
Transactions as of: Sep 29, 2023
Transactions value $: $0
Form type: 3
Date filed: 10/3/2023, 05:15 PM
Next filing: Feb 15, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	KRTX	Common Stock						16.9K	Sep 29, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	KRTX	Option (right to buy)							Sep 29, 2023	Common Stock	3.28K	$99.72	Direct	F2, F3
holding	KRTX	Option (right to buy)							Sep 29, 2023	Common Stock	6.56K	$131.64	Direct	F4, F5
holding	KRTX	Option (right to buy)							Sep 29, 2023	Common Stock	10.3K	$111.97	Direct	F6, F7
holding	KRTX	Option (right to buy)							Sep 29, 2023	Common Stock	7.1K	$191.79	Direct	F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Comprised of 13,399 shares of common stock and 3,550 restricted stock units ("RSUs"), each RSU representing a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest annually in four 25% installments commencing on February 13, 2024, subject to continued service through such dates.
F2	This option vests as to 25% of the shares on the first anniversary of the vesting commencement date of February 14, 2020, with additional vesting as to 6.25% of the shares underlying the option award on each three month anniversary thereafter.
F3	The option grant was originally for options to purchase 17,500 shares of the Issuer's common stock, of which 14,219 have already been exercised.
F4	This option vests as to 25% of the shares on the first anniversary of the vesting commencement date of February 23, 2021, with additional vesting as to 6.25% of the shares underlying the option award on each three month anniversary thereafter.
F5	The option grant was originally for options to purchase 15,000 shares of the Issuer's common stock, of which 8,438 have already been exercised.
F6	This option vests as to 25% of the shares on the first anniversary of the vesting commencement date of February 16, 2022, with additional vesting as to 6.25% of the shares underlying the option award on each three month anniversary thereafter.
F7	The option grant was originally for options to purchase 15,000 shares of the Issuer's common stock, of which 4,688 have already been exercised.
F8	This option vests as to 25% of the shares on the first anniversary of the vesting commencement date of February 13, 2023, with additional vesting as to 6.25% of the shares underlying the option award on each three month anniversary thereafter.

Remarks:

Exhibit 24 - Power of Attorney